NCT04229381

Brief Summary

This trial studies how well physical therapy and progressive muscle relaxation works in improving physical performance and mood in older patients with stage IIIA-B or IV lung cancer who are undergoing treatment. Improving physical performance and mood may help older patients maintain an independent lifestyle by helping to improve their resilience, the ability to bounce back to normal functioning after a stressor or intervening health event such as treatment or disease progression. Giving physical therapy and progressive muscle relaxation may work in improving symptoms and quality of life in patients with lung cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 18, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

January 22, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2022

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

November 15, 2023

Completed
Last Updated

November 15, 2023

Status Verified

October 1, 2023

Enrollment Period

1.4 years

First QC Date

November 26, 2019

Results QC Date

June 5, 2023

Last Update Submit

October 24, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Recruitment Rates

    Recruitment rates will be defined as the proportion of screened older adults accrued relative to those approached in the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic. Successful recruitment rates will be defined as \>= 50% of older adults (\>= 60 years) approached agree to participate.

    Up to 24 weeks

  • Adherence Rate

    Study adherence will be defined as the completion of \>= 70% of the program sessions, repeated assessments, and collection of bio specimens either at the end of the study period or death, whichever occurs first.

    Up to 24 weeks

  • Retention Rates

    Retention rates will be defined as the percentage of participants not lost to follow-up.

    Up to 24 weeks

Secondary Outcomes (2)

  • Functional Trajectories

    At 12 months

  • Factors Associated With Resiliency

    Up to 12 months

Study Arms (1)

Supportive Care (physical therapy, muscle relaxation)

EXPERIMENTAL

Patients participate physical therapy sessions consisting of cardiovascular and resistance training exercises in person or online and also undergo progressive muscle relaxation sessions once weekly for up to 12 weeks.

Procedure: Physical TherapyOther: Quality-of-Life AssessmentOther: Questionnaire AdministrationProcedure: Relaxation Therapy

Interventions

Undergo physical therapy

Also known as: Physiatric Procedure, Physical Medicine Procedure, Physical Therapeutics, Physical Therapy Procedure, Physiotherapy, Physiotherapy Procedure, PT
Supportive Care (physical therapy, muscle relaxation)

Ancillary studies

Also known as: Quality of Life Assessment
Supportive Care (physical therapy, muscle relaxation)

Ancillary studies

Supportive Care (physical therapy, muscle relaxation)

Undergo progressive muscle relaxation

Supportive Care (physical therapy, muscle relaxation)

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with advanced lung cancer: unresectable stage IIIA, IIIB, or stage IV non-small cell lung cancer (NSCLC) or extensive stage small cell lung cancer (SCLC).
  • Intent to receive treatment from the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic.
  • Willingness to participate and adhere to the study intervention program.
  • Ability to understand and willingness to sign an informed consent document (or indicate approval or disapproval by another means).

You may not qualify if:

  • Prisoners are excluded from participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

Location

Related Links

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Physical Therapy ModalitiesRelaxation Therapy

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationMind-Body TherapiesComplementary TherapiesBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Limitations and Caveats

Study opened in February of 2020 and COVID-19 lockdown in Ohio occurred in March of 2020. We had participants already in this first month of accrual who did decide to dropout due to COVID-19 related concerns. The study design was modified as most patients were being seen via virtual health for standard oncology care visits. The first and final intervention sessions were in-person with the remainder conducted via virtual health.

Results Point of Contact

Title
Dr. Carolyn Presley
Organization
The Ohio State University Comprehensive Cancer Center

Study Officials

  • Carolyn J Presley, MD, MHS

    Ohio State University Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 26, 2019

First Posted

January 18, 2020

Study Start

January 22, 2020

Primary Completion

June 22, 2021

Study Completion

June 22, 2022

Last Updated

November 15, 2023

Results First Posted

November 15, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations